John Leonard
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intellia Therapeutics, Inc. (NTLA) | CEO | $708,000 | $5,063,899 |
| 2024 | Intellia Therapeutics, Inc. (NTLA) | CEO | $687,000 | $15,330,547 |
| 2023 | Intellia Therapeutics, Inc. (NTLA) | CEO | $660,000 | $11,657,262 |
| 2022 | Intellia Therapeutics, Inc. (NTLA) | CEO | $630,000 | $10,096,590 |
| 2021 | Intellia Therapeutics, Inc. (NTLA) | CEO | $600,000 | $9,773,560 |
| 2020 | Intellia Therapeutics, Inc. (NTLA) | CEO | $580,000 | $3,635,676 |
| 2019 | Intellia Therapeutics, Inc. (NTLA) | CEO | $559,200 | $903,786 |
| 2018 | Intellia Therapeutics, Inc. (NTLA) | CEO | $550,000 | $9,708,330 |
| 2017 | Intellia Therapeutics, Inc. (NTLA) | CEO | $395,833 | $2,592,874 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.